ArticlePloS one2022
Assessment of COVID-19 vaccine hesitancy among Zimbabweans: A rapid national survey.
Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Vaccine hesitancy in context of COVID-19 in East Africa: systematic review and meta-analysis.BMC public health · 2024Pooled it
- Zimbabwe adverse events following immunisation surveillance system: A descriptive study with COVID-19 vaccine safety updates.Southern African journal of infectious diseases · 2026Article
- COVID-19 vaccine uptake in Zimbabwe and Sierra Leone: an application of Health Belief Model constructs.BMC public health · 2025Article
- Factors associated with COVID-19 vaccine uptake and hesitancy among women of reproductive age in Mozambique.Frontiers in public health · 2025Article
- COVID-19 vaccine utilisation among people living with HIV on antiretroviral therapy in Zimbabwe.Journal of public health in Africa · 2025Article
- Barriers and enhancers to COVID-19 vaccination among healthcare workers in Zimbabwe.Journal of public health in Africa · 2025Article
- Context matters: How to research vaccine attitudes and uptake after the COVID-19 crisis.Human vaccines & immunotherapeutics · 2024Article
- Knowledge, attitude, and perception towards COVID-19 vaccinations among the adults in Rwanda: a cross-sectional study.BMC public health · 2024Article
- Community responses to corona virus disease (COVID-19) in Africa in the face of "Infodemic": A scoping review.Parasite epidemiology and control · 2024Article
- Factors associated with COVID-19 vaccine receipt among mobile phone users in Malawi: Findings from a national mobile-based syndromic surveillance survey, July 2021-April 2022.PLOS global public health · 2024Article
- Structural and social factors affecting COVID-19 vaccine uptake among healthcare workers and older people in Uganda: A qualitative analysis.PLOS global public health · 2024Article
- A scoping review of COVID-19 vaccine hesitancy: refusal rate, associated factors, and strategies to reduce.Frontiers in public health · 2024Article
- Relative contribution of biomedical, demographic, and socioeconomic factors to COVID-19 vaccine receipt in rural India.PloS one · 2024Article
- Confidence in COVID-19 vaccine effectiveness and safety and its effect on vaccine uptake in Tanzania: A community-based cross-sectional study.Human vaccines & immunotherapeutics · 2023Article
- Vaccine inequity: a threat to Africa's recovery from COVID-19.Tropical medicine and health · 2023Review
- Barriers and Motivators toward Childhood COVID-19 Vaccination: A Cross-Sectional Study Conducted among Saudi Population.Medicina (Kaunas, Lithuania) · 2023Article
- Correlates of uptake of COVID-19 vaccines and motivation to vaccinate among Malawian adults.Human vaccines & immunotherapeutics · 2023Article
- Assessment of COVID-19 vaccine acceptance and its associated factors in Debre Berhan City, Ethiopia, 2022.PloS one · 2023Article
- COVID-19 vaccine uptake and associated factors among adolescents and youths: Findings and implications for future vaccination programmes.PLOS global public health · 2023Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAs a way of minimising the devastating effects of the coronavirus disease 2019 (COVID-19) pandemic, scientists hastily developed a vaccine. However, the scale-up of the vaccine is likely to be hindered by the widespread social media misinformation. We therefore conducted a study to assess the COVID-19 vaccine hesitancy among Zimbabweans.
methodsWe conducted a descriptive online cross-sectional survey using a self-administered questionnaire among adults. The questionnaire assessed willingness to be vaccinated; socio-demographic characteristics, individual attitudes and perceptions, effectiveness and safety of the vaccine. Multivariable logistic regression analysis was utilized to examine the independent factors associated with vaccine uptake.
resultsWe analysed data for 1168 participants, age range of 19-89 years with the majority being females (57.5%). Half (49.9%) of the participants reported that they would accept the COVID-19 vaccine. Majority were uncertain about the effectiveness of the vaccine (76.0%) and its safety (55.0%). About half lacked trust in the government's ability to ensure availability of an effective vaccine and 61.0% mentioned that they would seek advice from a healthcare worker to vaccinate. Chronic disease [vs no chronic disease-Adjusted Odds Ratio (AOR): 1.50, 95% Confidence Interval (CI)I: 1.10-2.03], males [vs females-AOR: 1.83, 95%CI: 1.37-2.44] and being a healthcare worker [vs not being a health worker-AOR: 1.59, 95%CI: 1.18-2.14] were associated with increased likelihood to vaccinate.
conclusionWe found half of the participants willing to vaccinate against COVID-19. The majority lacked trust in the government and were uncertain about vaccine effectiveness and safety. The policy makers should consider targeting geographical and demographic groups which were unlikely to vaccinate with vaccine information, education and communication to improve uptake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.